Agios Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	89.13	76.25	88.21	139.26	203.13
Short-Term Investments	765.3	817.46	688.72	643.86	816.89
Cash & Short-Term Investments	854.43	893.71	776.93	783.12	1,020
Cash Growth	-4.40%	15.03%	-0.79%	-23.23%	78.04%
Accounts Receivable	10.58	4.11	2.81	2.21	-
Other Receivables	-	-	-	-	4.38
Total Trade Receivables	10.58	4.11	2.81	2.21	4.38
Inventory	32.92	27.62	19.08	8.49	-
Other Current Assets	44.13	40.17	35.02	38.96	39.84
Total Current Assets	942.05	965.6	833.84	832.77	1,064
Net Property, Plant & Equipment	41.23	54.55	69.79	88.12	104.23
Long-Term Investments	310.01	638.32	29.44	313.87	266.38
Other Long-Term Assets	3.93	4.72	4.06	3.96	2.9
Total Assets	1,297	1,663	937.12	1,239	1,438
Accounts Payable	18.36	16.64	9.78	18.62	16.7
Accrued Expenses	45.46	46.86	43.17	30.35	31.97
Current Portion of Leases	18.39	16.78	15.01	13.66	11.16
Other Current Liabilities	-	0.87	-	-	-
Total Current Liabilities	82.21	81.16	67.96	62.63	59.83
Long-Term Leases	21.82	40.21	56.99	72	85.94
Other Long-Term Liabilities	0.09	0.88	1.16	3.28	-
Total Long-Term Liabilities	21.91	41.09	58.14	75.28	85.94
Total Liabilities	104.11	122.24	126.1	137.9	145.76
Common Stock	0.08	0.07	0.07	0	0.07
Treasury Stock	-802.49	-802.49	-802.49	-802.49	-802.49
Additional Paid-in Capital	2,555	2,494	2,437	2,386	2,334
Accumulated Other Comprehensive Income	2.19	-1.52	-0.44	-12.54	-1.2
Retained Earnings	-561.71	-148.92	-822.65	-470.56	-238.76
Shareholders' Equity	1,193	1,541	811.02	1,101	1,292
Total Liabilities & Equity	1,297	1,663	937.12	1,239	1,438
Total Debt	40.21	56.99	72	85.66	97.09
Net Cash (Debt)	814.22	836.72	704.93	697.46	922.92
Net Cash Growth	-2.69%	18.70%	1.07%	-24.43%	97.32%
Net Cash Per Share	14.04	14.45	12.67	12.73	15.27
Book Value	1,193	1,541	811.02	1,101	1,292
Book Value Per Share	20.58	26.62	14.57	20.09	21.37
Tangible Book Value	1,193	1,541	811.02	1,101	1,292
Tangible Book Value Per Share	20.58	26.62	14.57	20.09	21.37

Updated Feb 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q